Back to search

Virocell Biologics Ltd

13033264

in administration
Private Limited Company
Companies House
Health Score
N/A

Details

FRP ADVISORY TRADING LTD, LONDON, EC4N 6EU
Incorporated 20/11/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

John Winthrop Hadden

director · Since 28/01/2021

DIRECTOR

AMERICAN · UNITED STATES · Age 56

Dr Farzin Farzaneh

director · Since 28/01/2021

DIRECTOR

BRITISH · UNITED KINGDOM · Age 72

Also on 3 other boards

Todd C Davis

director · Since 14/04/2021

PHARMACEUTICAL EXECUTIVE

AMERICAN · UNITED STATES · Age 65

John David Enloe

director · Since 01/07/2021

NON EXECUTIVE DIRECTOR

AMERICAN · UNITED STATES · Age 62

Susan Dexter

director · Since 09/02/2023

NON-EXECUTIVE DIRECTOR

AMERICAN · UNITED STATES · Age 70

John Andrew Dawson

director · Since 13/02/2023

NON-EXECUTIVE DIRECTOR

BRITISH · UNITED KINGDOM · Age 66

Cedriane Marie De Boucaud Truell

director · Since 01/09/2023

DIRECTOR

BRITISH · SWITZERLAND · Age 56

Persons with Significant Control

Sartorius Stedim Biotech Gmbh

25–50% shares
25–50% votes

August-Spindler, Strasse 11, Goettingen, 37079

Reg: 200266 · District Court · Private Limited Company

Notified 31/07/2023

Former PSCs

Edmund George Imjin Fosbroke Truell

Ceased 29/01/2021

The Truell Conservation Foundation

Ceased 31/07/2023

Todd C Davis

Ceased 14/04/2021

Amie B Hadden

Ceased 14/04/2021

Mr Todd Davis

Ceased 31/07/2023

Long Term Assets Limited

Ceased 18/05/2022

Charges1 outstanding

Charge
outstanding

NICHOLAS DENZIL STEPHENS FOR AND ON BEHALF OF THE SECURED PARTIES

Created 29/09/2025Registered 30/09/2025

CompanyRankvs 15+ SIC 72110 peers
27

Financial strengthNo net worth data · 0/25
EmployeesNo employee data · 0/15
LiquidityCurrent ratio 1.5× · 16/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2023

Net Worth

£157

Balance sheet strength

Cash

£6.1M

Cash in the bank

Net Current Assets

£2.2M

Working capital

Current Assets

£6.5M

Current Liabilities

£4.4M

Fixed Assets

£1.2M

Debtors

£496k

Profit After Tax

-£6.4M

57avg. employees+20

Balance Sheet

Intangible assets£83k
Assets less current liabilities£3.4M
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20231.50
20226.18
20210.58

Derived from filed accounts. Not audited figures.